Citations

Showing 10 of 108083 citations.

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
Tjin, Gavin , White, Eric S. , Faiz, Alen , Tschumperlin, Daniel J. , Mahar, Annabelle , Kable, Eleanor , Burgess, Janette K. , Sicard, Delphine , Tjin, Gavin , Sicard, Delphine , Tschumperlin, Daniel J , Mahar, Annabelle , Kable, Eleanor P W , Burgess, Janette K , White, Eric S , Tjin, Gavin

Mayo Clinic

Disease Models & Mechanisms | November 6, 2017 | Volume: 10 | Issue: 11 | Pages: 1301-1312

10.1242/dmm.030114 | PMID 29125826 Get It

ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with few effective therapeutic options. Structural remodelling of the extracellular matrix [i.e. collagen cross-linking mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1-4)] might contribute to disease pathogenesis and represent a therapeutic target. This study aimed to further our understanding of the mechanisms by which LO inhibitors might improve lung fibrosis. Lung tissues from IPF and non-IPF subjects were examined for collagen structure (second harmonic generation imaging) and LO gene (microarray analysis) and protein (immunohistochemistry and western blotting) levels. Functional effects (collagen structure and tissue stiffness using atomic force microscopy) of LO inhibitors on collagen remodelling were examined in two models, collagen hydrogels and decellularized human lung matrices. LOXL1/LOXL2 gene expression and protein levels were increased in IPF versus non-IPF. Increased collagen fibril thickness in IPF versus non-IPF lung tissues correlated with increased LOXL1/LOXL2, and decreased LOX, protein expression. β-Aminoproprionitrile (β-APN; pan-LO inhibitor) but not Compound A (LOXL2-specific inhibitor) interfered with transforming growth factor-β-induced collagen remodelling in both models. The β-APN treatment group was tested further, and β-APN was found to interfere with stiffening in the decellularized matrix model. LOXL1 activity might drive collagen remodelling in IPF lungs. The interrelationship between collagen structural remodelling and LOs is disrupted in IPF lungs. Inhibition of LO activity alleviates fibrosis by limiting fibrillar collagen cross-linking, thereby potentially impeding the formation of a pathological microenvironment in IPF.
Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study
Zinsmeister, Alan R., Herrick, Linda M., Saito, Yuri A. , Schleck, Cathy D. , Saito Loftus, Yuri A, Talley, Nicholas J.

Mayo Clinic

Scandinavian Journal of Gastroenterology | November 6, 2017 | Volume: 53 | Issue: 5 | Pages: 549-558

10.1080/00365521.2017.1395908 | PMID 29103329 Get It

Characteristics of Patients With Existing Advance Directives: Evaluating Motivations Around Advance Care Planning
Genewick, Joanne E., Lipski, Dorothy M. , Schupack, Katherine M. , Buffington, Angela L.H.

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | November 6, 2017 | Volume: 35 | Issue: 4 | Pages: 664-668

10.1177/1049909117731738 | PMID 28925295 Get It

Introduction: Although 80% of patients endorse an advance directive (AD), less than 35% of American adults have a documented AD. Much research has been done on barriers to creating ADs; however, there is a paucity of research addressing motivations for creating ADs. Previous research has identified 4 categories of influence for engaging in advance care planning (ACP). This study aimed to quantify the influence of these 4 motivating categories in creating an AD. Methods: Participants included 238 adults with documented ADs. Participants completed an 11-item questionnaire addressing 1 of the 4 hypothesized categories of influence in addressing ACP: concern for self; concern for others; expectations about the impact of ACP; and anecdotes, stories, and experiences. Results: Principle component analysis yielded 2 factors representing dignity and personal control (intrinsic factors) and societal and familial influence (extrinsic factors). Intrinsic factors were the primary and most influential motivating factors among participants. A regression analysis of individual motivating factors showed that prior to age 50, the desire to provide guidance about personal preferences for end-of-life care significantly predicted the creation of an AD, whereas after age 50, the urging of family members significantly predicted the creation of an AD. Discussion: Results indicated that intrinsic factors were the most influential motivator among participants of all ages. Extrinsic factors appeared to be less influential in the decision to create an AD. Motivating factors were also found to vary by age. These results may help physicians be more targeted in discussions surrounding ADs, thus saving time, which physicians identify as the main barrier in engaging in such discussions, while meeting patients’ wishes for their physicians to bring up the topic of ADs.
Occupational Variation in End-of-Life Care Intensity
Hyder, Joseph A. , Sturgeon, Daniel J. , Gazarian, Priscilla , Jiang, Wei , Cooper, Zara , Lipsitz, Stuart R. , Sturgeon, Daniel , Häring, R , Prigerson, Holly Gwen , Weissman, Joel S.

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | November 6, 2017 | Volume: 35 | Issue: 3 | Pages: 377-383

10.1177/1049909117710633 | PMID 28571496 Get It

Background: End-of-life (EOL) care intensity is known to vary by secular and geographic patterns. US physicians receive less aggressive EOL care than the general population, presumably the result of preferences shaped by work-place experience with EOL care. Objective: We investigated occupation as a source of variation in EOL care intensity. Methods: Across 4 states, we identified 660 599, nonhealth maintenance organization Medicare beneficiaries aged ≥66 years who died between 2004 and 2011. Linking death certificates, we identified beneficiaries with prespecified occupations: nurses, farmers, clergy, mortuary workers, homemakers, first-responders, veterinary workers, teachers, accountants, and the general population. End-of-life care intensity over the last 6 months of life was assessed using 5 validated measures: (1) Medicare expenditures, rates of (2) hospice, (3) surgery, (4) intensive care, and (5) in-hospital death. Results: Occupation was a source of large variation in EOL care intensity across all measures, before and after adjustment for sex, education, age-adjusted Charlson Comorbidity Index, race/ethnicity, and hospital referral region. For example, absolute and relative adjusted differences in expenditures were US$9991 and 42% of population mean expenditure ( P < .001 for both). Compared to the general population on the 5 EOL care intensity measures, teachers (5 of 5), homemakers (4 of 5), farmers (4 of 5), and clergy (3 of 5) demonstrated significantly less aggressive care. Mortuary workers had lower EOL care intensity (4 of 5) but small numbers limited statistical significance. Conclusion: Occupations with likely exposure to child development, death/bereavement, and naturalistic influences demonstrated lower EOL care intensity. These findings may inform patients and clinicians navigating choices around individual EOL care preferences.
The Experience of Hospital Death: Assessing the Quality of Care at an Academic Medical Center
Carey, Elise C. , Dose, Ann Marie , Humeniuk, Katherine M., Kuan, Yichen C., Hicks, Ashley, Ottenberg, Abigale L., Tilburt, Jon C. , Koenig, Barbara A. , Dose, Ann M, Hicks, Ashley D

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | November 6, 2017 | Volume: 35 | Issue: 2 | Pages: 189-197

10.1177/1049909116689547 | PMID 28103711 Get It

Background: The quality of perimortem care received by patients who died at our hospitals was unknown. Objective: To describe the quality of hospital care experienced in the last week of life, as perceived by decedents’ families. Design: Telephone survey that included established measures and investigator-developed content. Setting: Large, tertiary care center known for high-quality, cost-effective care. Participants: Family members of 104 patients who died in-hospital (10% of annual deaths) over the course of 1 year. Intervention: None. Measurements: Participant perceptions of the decedent’s care, including symptom management, personal care, communication, and care coordination. Results: Decedents were mostly male (64%), white (96%), married (73%), and Christian (91%). Most survey participants were spouses of the decedent (68%); they were predominately white (98%), female (70%), and Christian (90%) and had a median age of 70 years (range, 35-91 years). Overall satisfaction was high. Pain, dyspnea, and anxiety or sadness were highly prevalent among decedents (73%, 73%, and 55%, respectively) but largely well managed. Most participants believed that decedents were treated respectfully and kindly by staff (87%) and that sufficient help was available to assist with medications and dressing changes (97%). Opportunities for improvement included management of decedents’ anxiety or sadness (29%) and personal care (25%), emotional support of the family (57%), communication regarding decedents’ illness (29%), and receiving contradictory or confusing information (33%). Conclusion: Despite high satisfaction with care overall, we identified important unmet needs. Addressing these gaps will improve the care of dying patients.
Methodological standards and functional correlates of depth in vivo electrophysiological recordings in control rodents. A TASK1‐WG3 report of the AES/ILAE Translational Task Force of the ILAE
Hernan, Amanda E. , Schevon, Catherine A. , Kahane, Philippe , Curtis, Marco de , Quilichini, Pascale , Williamson, Adam , Garcia‐Cairasco, Norberto, Scott, Rod C. , Timofeev, Igor , Worrell, Gregory A. , Galanopoulou, Aristea S. , Ikeda, Akio , Garcia‐Cairasco, Norberto

Mayo Clinic

Epilepsia | November 6, 2017 | Volume: 58 | Issue: S4 | Pages: 28-39

10.1111/epi.13905 | PMID 29105069 Get It

SummaryThis paper is a result of work of the AES/ILAE Translational Task Force of the International League Against Epilepsy. The aim is to provide acceptable standards and interpretation of results of electrophysiological depth recordings in vivo in control rodents.
Transforming the Activation of Clinical Trials
Watters, Julie T., Pitzen, Jason H., Sanders, Linda J., Bruce, Virginia M., Cornell, Alissa R., Cseko, Gary C., Grace, Janice S., Kwon, Pamela S., Kukla, Andrea K., Lee, Michael S. , Monosmith, Michelle D., Myren, John D., Kottschade, Rebecca S., Shaft, Marc N., Weis, Jennifer A., Welter, Jane C., Bharucha, Adil E. , Bruce, Virginia Nickie M, Weis, Jennifer Jenny A, Bruce, Virginia M., Cseko, Gary C.

Mayo Clinic

Clinical Pharmacology & Therapeutics | November 6, 2017 | Volume: 103 | Issue: 1 | Pages: 43-46

10.1002/cpt.898 | PMID 29105757 Get It

The Institute of Medicine and US Food and Drug Administration (FDA) recognize that activating clinical trials in the United States is lengthy and inefficient. Downstream consequences include increased expense, suboptimal accrual, move of clinical trials overseas, and delayed availability of treatments for patients. An in‐tandem processing initiative is here highlighted that transformed the activation of clinical trials (TACT), reduced the activation time by 70%, and offers a paradigm for enhanced translational readiness.
MRI-guided preoperative 125 I seed localizations: Case report
Lee, Christine U. , Lee, Christine

Mayo Clinic

The Breast Journal | November 5, 2017 | Volume: 24 | Issue: 3 | Pages: 397-399

10.1111/tbj.12938 | PMID 29105881 Get It

Historical epidemiology of hepatitis C virus in select countries—volume 4
Vince, Adriana , Himatt, Sayed , Mohamed, Rosmawati , Opare‐Sem, Ohene , Workneh, A., Njouom, Richard , Ghazzawi, Imad, Abdulla, Maheeba , Kaliaskarova, Kulpash , Owusu‐Ofori, Shirley , Abdelmageed, Marwa , Adda, Danjuma, Baqali, A. Al, Dweik, N. Al, Ejji, Khalid Al, Kaabi, S. Al, Naamani, Khalid Al , Qamish, Jehad Al, Sadadi, M. Al, Salman, Jameela Al , AlBadri, M., Al‐Busafi, Said A. , Al‐Romaihi, Hamad Eid , Ampofo, William , Antonov, Krasimir , Anyaike, Chukwuma , Arome, F., Bane, Abate, Borodo, M. M., Brandon, S., Bright, Bisi , Butt, M. T., Cardenas, I., Chan, Henry Lik‐Yuen , Chen, C. J., Chen, Ding‐Shinn , Chen, Pei‐Jer , Cuellar, Diego , Derbala, M., Elbardiny, A. A., Estes, Chris , Farag, E., Gamkrelidze, Ivane , Garcìa, V. , Genov, J, Ghandour, Z., Ghuloom, M., Gómez, B. , Gunter, J., Habeeb, J., Hajelssedig, O. , Hamoudi, Waseem , Hrstić, Irena , Hu, Ching‐Chih , Huang, Chung‐Feng , Hui, Yee Tak , Jahis, Rohani, Jelev, Deian, John, Anil K , Kamel, Yasser , Kao, Jia‐Horng , Khamis, Jawad, Khattabi, H., Khoudri, Ibtissam , Конысбекова, А А , Kotzev, Iskren, Lai, Moon Sing, Lao, Wenyu, Layden, Jennifer E. , Lee, M. H., Lesi, Olufunmilayo , Li, M., Loo, Ching‐kong, Lukšić, Boris, Malu, Abraham O., Mateva, Lyudmila, Mitova, R, Morović, Miro, Murphy, K., Mustapha, B., Nde, H. , Nersesov, Alexander , Ngige, Evelyn, Njoya, Oudou, Nonković, Diana , Obekpa, Solomon, Oguche, Stephen , Okolo, Eucharia, Omede, O. , Omuemu, C., Phillips, Richard Odame , Prokopenko, Yuriy , Razavi, Homie , Razavi‐Shearer, Devin , Redae, Berhane, Reić, Tatjana, Wit, Tobias Rinke de, Ríos, Cielo , Robbins, S., Roberts, Lewis R. , Sanad, S. J., Schmelzer, Jonathan, Sharma, Manik , Simonova, Marieta, Su, Tung‐Hung , Sultan, K., Tan, S. S. , Tchernev, К., Tsang, O. T. Y., Tsang, S., Tzeuton, Christian, Ugoeze, S., Vi, R., Wani, Hamid, Yacoub, R., Yesmembetov, Kakharman, Youbi, M., Razavi‐Shearer, Kathryn , Wong, Grace Lai‐Hung , Roberts, Lewis R , Fung, James , Akın, Onur , Blach, Sarah , Chien, Rong‐Nan , Chuang, Wan‐Long , Lee, M.-H., Lo, Acy , Ondoa, Pascale , Wit, Tobias F. Rinke de , Robbins, S., Uzochukwu, Benjamin S C. , Wong, Vincent Wai‐Sun , Yuen, Man‐Fung , Lai-Hung Wong, Grace

Mayo Clinic

Journal of Viral Hepatitis | November 4, 2017 | Volume: 24 | Issue: S2 | Pages: 8-24

10.1111/jvh.12762 | PMID 29105285 Get It

SummaryDue to the introduction of newer, more efficacious treatment options, there is a pressing need for policy makers and public health officials to develop or adapt national hepatitis C virus (HCV) control strategies to the changing epidemiological landscape. To do so, detailed, country‐specific data are needed to characterize the burden of chronic HCV infection. In this study of 17 countries, a literature review of published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates was conducted, and inputs were validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Hong Kong to 2.4% in Taiwan, while the largest viraemic populations were in Nigeria (2 597 000 cases) and Taiwan (569 000 cases). Diagnosis, treatment and liver transplant rates varied widely across the countries included in this analysis, as did the availability of reliable data. Addressing data gaps will be critical for the development of future strategies to manage and minimize the disease burden of hepatitis C.